Related Experiment Video
Updated: Aug 17, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Use of daytime phototherapy for Crigler-Najjar disease
Andy Nydegger1, Andrew Bednarz, Winita Hardikar
1Department of Gastroenterology and Nutrition, Royal Children's Hospital, Melbourne, Australia.
Insights
Crigler-Najjar syndrome type 1 (CNS1) management improved with a novel sit-up phototherapy unit. This innovation reduced treatment time by 50%, allowing affected children more freedom and school attendance.
Area of Science:
- Medical Genetics
- Neonatology
- Phototherapy
Background:
- Crigler-Najjar syndrome type 1 (CNS1) causes severe unconjugated hyperbilirubinemia from birth.
- Standard management involves intensive blue-light phototherapy, significantly restricting patient and family lifestyle.
Observation:
- A novel sit-up phototherapy unit was utilized in a pediatric patient with CNS1.
- This innovative approach aimed to improve treatment efficiency and patient comfort.
Findings:
- The sit-up phototherapy unit achieved a 50% reduction in required treatment time.
- Therapeutic efficacy was maintained, effectively managing hyperbilirubinemia.
Implications:
- Reduced phototherapy duration enhances quality of life for children with CNS1.
- This advancement facilitates greater social integration and school attendance for affected individuals.
Abstract:
Crigler-Najjar syndrome type 1 (CNS1) is characterized by a severe unconjugated hyperbilirubinemia from birth. Intensive blue-light phototherapy is the standard method for management; however, it imposes severe restrictions on the child and their family's lifestyle. We describe here the use of a novel sit-up phototherapy unit in a child with CNS1. The unit allowed a 50% reduction in phototherapy time while maintaining efficacy, thus enabling the child to attend school.
Related Concept Videos
Acne Infection
Angle Closure Glaucoma: Treatment
